Home › Funds › HIGHBRIDGE CAPITAL MANAGEMENT LLC › IONS
HIGHBRIDGE CAPITAL MANAGEMENT LLC position in IONS
IONIS PHARMACEUTICALS INC · Health Care
HIGHBRIDGE CAPITAL MANAGEMENT LLC reported holding 57,588,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$64.1M, representing 2.24% of its reported portfolio and ranking #9 among its reported holdings. HIGHBRIDGE CAPITAL MANAGEMENT LLC has disclosed IONS holdings in 3 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How HIGHBRIDGE CAPITAL MANAGEMENT LLC's IONS position evolved
HIGHBRIDGE CAPITAL MANAGEMENT LLC first disclosed a stake in IONS in Q3 2024 at 25,500,000 shares (US$26.4M). The position peaked in Q3 2026 at 57,588,000 shares, worth US$64.1M. Across 3 filings, HIGHBRIDGE CAPITAL MANAGEMENT LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 57,588,000 shares valued at US$64.1M. Notable position changes include a 37% trim in Q4 2024 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 25.50M | $26.42M | New |
| Q4 2024 | 16.00M | $15.56M | Reduce |
| Q3 2026 | 57.59M | $64.13M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IONS and 13F data
IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 30 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$300.4M), TWO SIGMA ADVISERS, LP (US$241.5M), BAKER BROS. ADVISORS LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IONS
- Two Sigma Investments 6.73M sh · $300.38M · Q3 2026
- TWO SIGMA ADVISERS, LP 3.05M sh · $241.45M · Q4 2025
- BAKER BROS. ADVISORS LP 2.05M sh · $162.36M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 94.68M sh · $147.77M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 60.00M sh · $93.10M · Q2 2026
- Tweedy, Browne Co LLC 1.79M sh · $80.08M · Q3 2026
- Bellevue Group AG 972.26K sh · $77.09M · Q2 2026
- GROUPAMA ASSET MANAGMENT 937.08K sh · $75.20M · Q2 2026
More on HIGHBRIDGE CAPITAL MANAGEMENT LLC
FAQ
How long has HIGHBRIDGE CAPITAL MANAGEMENT LLC held IONS?
HIGHBRIDGE CAPITAL MANAGEMENT LLC has disclosed IONS holdings in 3 of the last 9 reported quarters, going back to Q3 2024.
What is HIGHBRIDGE CAPITAL MANAGEMENT LLC's current position in IONS?
As of Q3 2026, HIGHBRIDGE CAPITAL MANAGEMENT LLC holds 57.59M shares of IONS (IONIS PHARMACEUTICALS INC), valued at $64.13M, representing 2.24% of its reported portfolio and ranking #9.
Has HIGHBRIDGE CAPITAL MANAGEMENT LLC been buying or selling IONS?
In the latest 13F filing (Q3 2026), HIGHBRIDGE CAPITAL MANAGEMENT LLC newly opened its position in IONS. The position peaked in Q3 2026 at 57.59M shares.
Which other funds hold IONS?
Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, BAKER BROS. ADVISORS LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.